The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
The DETECT study concept: Individualized therapy of metastatic breast cancer.
 
Arkadius Polasik
No Relationships to Disclose
 
Amelie Schramm
No Relationships to Disclose
 
Thomas W. P. Friedl
Honoraria - Eisai
 
Brigitte Kathrin Rack
Honoraria - Roche Pharma AG
Consulting or Advisory Role - Novartis
Research Funding - Janssen Diagnostics
Travel, Accommodations, Expenses - Roche Pharma AG
 
Elisabeth Katharina Trapp
No Relationships to Disclose
 
Peter A. Fasching
Honoraria - Novartis
Research Funding - Novartis
 
Florin-Andrei Taran
No Relationships to Disclose
 
Andreas D. Hartkopf
No Relationships to Disclose
 
Andreas Schneeweiss
Honoraria - AstraZeneca; Chugai Pharma; Lilly; Novartis; Sanofi
Research Funding - AstraZeneca; Chugai Pharma; Lilly; Novartis; Sanofi
 
Volkmar Mueller
Honoraria - Amgen; AstraZeneca; Celgene; Eisai; Genomic Health; GlaxoSmithKline; Hexal; Janssen-Cilag; Medac; Novartis; Pierre Fabre; Roche/Genentech
Consulting or Advisory Role - Amgen; Celgene; Eisai; Genomic Health; Janssen-Cilag; Pierre Fabre
 
Bahriye Aktas
No Relationships to Disclose
 
Klaus Pantel
Honoraria - Janssen Diagnostics
Research Funding - Janssen Diagnostics
 
Franziska Meier-Stiegen
No Relationships to Disclose
 
Pauline Wimberger
Honoraria - Amgen; AstraZeneca; Fresenius Biotech; MSD; Novartis/Pfizer; PharmaMar; Roche Pharma AG; Teva
Consulting or Advisory Role - Amgen; AstraZeneca; Fresenius Biotech; MSD; Novartis/Pfizer; PharmaMar; Roche Pharma AG; Teva
Research Funding - Amgen; Fresenius Biotech; MSD; Novartis/Pfizer; PharmaMar; Roche Pharma AG
 
Wolfgang Janni
Honoraria - Janssen Diagnostics
Consulting or Advisory Role - Janssen Diagnostics
Research Funding - Janssen Diagnostics
 
Tanja N. Fehm
Consulting or Advisory Role - Amgen; Novartis; Roche
Speakers' Bureau - AstraZeneca; AstraZeneca; AstraZeneca; PharmaMar; Roche
Research Funding - Novartis